Interactions between E6AP and E6 proteins from alpha and beta HPV types

Virology

Volumn 435, Issue 2, 2013, Pages 357-362

  Thomas, Miranda ^a   Tomaić, Vjekoslav ^a   Pim, David ^a   Myers, Michael P ^a   Tommasino, Massimo ^b   Banks, Lawrence ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

E6; E6 AP; HPV

Indexed keywords

PROTEIN E6; PROTEIN E6AP; PROTEIN P600; PROTEIN UBR4; PROTEOME; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS ALPHA; HUMAN PAPILLOMAVIRUS BETA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UBIQUITINATION; WART VIRUS;

ALPHAPAPILLOMAVIRUS; BETAPAPILLOMAVIRUS; HEK293 CELLS; HUMANS; ONCOGENE PROTEINS, VIRAL; PROTEIN BINDING; PROTEOMICS; TRANSFECTION; UBIQUITIN-PROTEIN LIGASES;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 84871693768     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.11.004     Document Type: Article

References (31)

1. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Benbrahim-Tallaa L., Guha N., Freeman C., Galichet L., Cogliano V. WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens-Part B: Biological agents. Lancet Oncol. 2009, 10:321-322.
2. Brimer N., Lyons C., Vande Pol S.B. Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein. Virology 2007, 358:303-310.
3. Coleman M.L., Marshall C.J., Olson M.F. Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation. EMBO J. 2003, 22:2036-2046.
4. DeFee M.R., Qin Z., Dai L., Isaacs J.S., Parsons C.H. Interactions between Hsp90 and oncogenic viruses: implications for viral cancer therapeutics. Am. J. Cancer Res. 2011, 1:763-772.
5. DeMasi J., Huh K.W., Nakatani Y., Münger K., Howley P.M. Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding. Proc. Nat. Acad. Sci. U.S.A. 2005, 102:11486-11491.
6. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., Zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-27.
7. Howie H.L., Koop J.I., Weese J., Robinson K., Wipf G., Kim L., Galloway D.A. Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association. PLoS Pathog. 2011, 7:e1002211.
8. Huh K.W., DeMasi J., Ogawa H., Nakatani Y., Howley P.M., Münger K. Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600. Proc. Nat. Acad. Sci. U.S.A. 2005, 102:11492-11497.
9. Huibregtse J.M., Scheffner M., Howley P.M. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell Biol. 1993, 13:775-784.
10. Huibregtse J.M., Scheffner M., Beaudenon S., Howley P.M. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Nat. Acad. Sci. U.S.A. 1995, 92:2563-2567.
11. Jackson S., Harwood C., Thomas M., Banks L., Storey A. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev. 2000, 14:3065-3073.
12. Kao W.H., Beaudenon S.L., Talis A.L., Huibregtse J.M., Howley P.M. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase. J. Virol. 2000, 74:6408-6417.
13. Kehmeier E., Rühl H., Voland B., Stöppler M.C., Androphy E., Stöppler H. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities. Virology 2002, 299:72-87.
14. Leverrier S., Bergamaschi D., Ghali L., Ola A., Warnes G., Akgül B., Blight K., García-Escudero R., Penna A., Eddaoudi A., Storey A. Role of HPV E6 proteins in preventing UVB-induced release of pro-apoptotic factors from the mitochondria. Apoptosis 2007, 12:549-560.
15. Liu Y., Baleja J.D. Structure and function of the papillomavirus E6 protein and its interacting proteins. Front. Biosci. 2008, 13:121-134.
16. Massimi P., Thomas M., Bouvard V., Ruberto I., Campo M.S., Tommasino M., Banks L. Comparative transforming potential of different human papillomaviruses associated with non-melanoma skin cancer. Virology 2008, 371:374-379.
17. Muench P., Probst S., Schuetz J., Leiprecht N., Busch M., Wesselborg S., Stubenrauch F., Iftner T. Cutaneous papillomavirus E6 proteins must interact with p300 and block p53-mediated apoptosis for cellular immortalization and tumorigenesis. Cancer Res. 2010, 70:6913-6924.
18. Müller-Schiffmann A., Beckmann J., Steger G. The E6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms. J. Virol. 2006, 80:8718-8728.
19. Pim D., Thomas M., Banks L. Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins. Oncogene 2002, 21:8140-8148.
20. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993, 75:495-505.
21. Storey A., Thomas M., Kalita A., Harwood C., Gardiol D., Mantovani F., Breuer J., Leigh I.M., Matlashewski G., Banks L. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998, 393:229-234.
22. Thomas M., Banks L. Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene 1998, 17:2943-2954.
23. Thomas M., Banks L. Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types. J. Gen. Virol. 1999, 80:1513-1517.
24. Thomas M., Laura R., Hepner K., Guccione E., Sawyers C., Lasky L., Banks L. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 2002, 21:5088-5096.
25. Thomas M., Narayan N., Pim D., Tomaić V., Massimi P., Nagasaka K., Kranjec C., Gammoh N., Banks L. Human papillomaviruses, cervical cancer and cell polarity. Oncogene 2008, 27:7018-7030.
26. Tomaić V., Pim D., Banks L. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent. Virology 2009, 393:7-10.
27. Tomaić V., Gardiol D., Massimi P., Ozbun M., Myers M., Banks L. Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators. Oncogene 2009, 28:1-8.
28. Tomaić V., Pim D., Thomas M., Massimi P., Myers M.P., Banks L. Regulation of the human papillomavirus type 18 E6/E6AP ubiquitin ligase complex by the HECT domain-containing protein EDD. J. Virol. 2011, 85:3120-3127.
29. Underbrink M.P., Howie H.L., Bedard K.M., Koop J.I., Galloway D.A. E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. J. Virol. 2008, 82:10408-10417.
30. Wigler M., Sweet R., Sim G.K., Wold B., Pellicer A., Lacy E., Maniatis T., Silverstein S., Axel R. Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell 1979, 16(4):777-785.
31. White E.A., Kramer R.E., Tan M.J., Hayes S.D., Harper J.W., Howley P.M. Comprehensive analysis of host cellular interactions with human papillomavirus E6 proteins identifies new E6 binding partners and reflects viral diversity. J. Virol. 2012, in press.